ArticlePloS one2017

Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.

Yi-Jin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.